Sopharma
is one of the leading pharmaceutical company in Bulgaria,
popular with manufacturing of high-quality medicines. In
its striving to be among the most successful firms, Sopharma
combines traditions of the Bulgarian pharmaceutical knoweldge
with modern business ethic and corporate responsibility
to society's needs .
In the spring of 1933, in the suburbs of Sofia, the beginning
of Bulgarian pharmaceutical manufacture was initiated with
the building of the first manufacturing laboratory for pharmaceuticals.
This was also the beginning of Sopharma - one of the most
successful Bulgarian enterprises of all times. Irrespective
of the form of property - private cooperative, socialist
state-owned, private joint-stock company, for 70 years now
Sopharma continues to be an embodiment of the human striving
for health and humanity. This name symbolizes the work of
many people who for decades on end, carefully and responsibly,
have been creating remedies for the pains of other people.
The trust of millions Bulgarians is a priceless reward for
their dedicated work. This explains the fact that today
as well Sopharma continues to be one of the largest manufacturers
of pharmaceuticals - a warrantor of quality and reliability.
Established
as a small manufacturing laboratory with the Bulgarian Pharmaceutical
Cooperative Society in 1942, the company grew into Galenus
Factory, the first modern pharmaceutical enterprise on the
Balkan Peninsula.
After its nationalization in 1953, Galenus Factory was renamed
to Chemical-Pharmaceutical Plant.
After the successful privatization in September 2000, Sopharma
has become a private pharmaceutical company with priorities
aimed at the establishment of the world standards for quality
and efficiency.
The accomplishment of the investment program, adopted by
Sopharma, includes renovation of manufacture and technological
facilities, modernization of assets for research and development,
restructuring of research and development sector.
The ambitious investments are an expression of our clear
conception of the future which will help us to be among
the best companies in the pharmaceutical business and to
create medicines as an actual contribution to our care for
human health.
The highly sophisticated process of the creation and manufacture
of pharmaceuticals has been licensed in compliance with
the Good Manufacturing Practices. The main production facilities
have been modernized and new production departments and
plants have been opened.
The manufacture of high-quality pharmaceuticals complying
with European standards and Bulgarian legal regulations
is a priority task in the company policy of Sopharma.
A total of 110 medicines of almost all pharmaceutical groups,
build the product portfolio of our Company. Well-known in
the country and abroad, the pharmaceuticals with Sopharma's
trademark are an approved guarantee of quality and efficiency
nowadays. |